Clinical Trial Update: Designing a Bayesian Model of the Plasma Clearance of Calcium Edetate de Sodium for the Calculation of GFR and Validity Compared to the Renal Clearance of Inulin [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating a Bayesian model of plasma clearance of calcium edetate disodium for estimating GFR compared to inulin clearance, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Disease

Drugs mentioned

• calcium edetate disodium (calcium edetate disodium)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Kidney Disease | Phase 3 | Status: COMPLETED